Who owns the MOLECULAR THERAPY ONCOLYTICS trademark?

The MOLECULAR THERAPY ONCOLYTICS trademark is owned by The American Society of Gene & Cell Therapy.

What class is the MOLECULAR THERAPY ONCOLYTICS trademark registered in?

The MOLECULAR THERAPY ONCOLYTICS trademark is registered in Class 009 (Electronics, software & scientific instruments), Class 041 (Education & entertainment services).

What is the serial number for MOLECULAR THERAPY ONCOLYTICS?

The USPTO serial number for MOLECULAR THERAPY ONCOLYTICS is 90454786.

What is the registration number for MOLECULAR THERAPY ONCOLYTICS?

MOLECULAR THERAPY ONCOLYTICS is registered under USPTO registration number 6920626.

MOL

USPTO Trademark Record

REGISTERED

MOLECULAR THERAPY ONCOLYTICS

SN 90454786·Reg 6920626·Filed Jan 08, 2021

Owner The American Society of Gene & Cell Therapy

Scientific, research, navigation, surveying, photographic, cinematographic, audiovisual, optical, weighing, measuring, signalling, detecting, testing, inspecting, life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling the distribution or use of electricity; apparatus and instruments for recording, transmitting, reproducing or processing sound, images or data; recorded and downloadable multimedia files, computer software, blank digital or analogue recording and storage media; mechanisms for coin-operated apparatus; cash registers, calculating devices; computers and computer peripheral devices; diving suits, divers' masks, ear plugs for divers, nose clips for divers, gloves for divers, breathing apparatus for underwater swimming; fire-extinguishing apparatus.; Education; providing of training; entertainment; sporting and cultural activities.

MOLECULAR THERAPY ONCOLYTICS (Serial No. 90454786), Registration No. 6920626, is a registered US trademark filed on Jan 08, 2021 by The American Society of Gene & Cell Therapy. This trademark covers Class 009 (Electronics, software & scientific instruments), Class 041 (Education & entertainment services).

early section 8: December 13, 2028

Mark Intelligence

MOLECULAR THERAPY ONCOLYTICS (Reg. #6920626) is a registered US trademark that has been protecting its owner, The American Society of Gene & Cell Therapy, since 2021. The mark covers Class 009 (Electronics, software & scientific instruments) and Class 041 (Education & entertainment services) respectively. Goods and services include Scientific, research, navigation, surveying, photographic, cinematographic, audiovisual, optical, weighing, measuring, s.... The mark faced 1 opposition proceeding during prosecution.

FILED

Jan 08, 2021

SERIAL

90454786

REG#

6920626

REGISTERED

Dec 13, 2022

Owner

Applicant

The American Society of Gene & Cell Therapy

Entity

Corporation

State

Address

20800 Swenson Drive, Suite 300, Waukesha, WI, 53186

Country

Attorney

NamePatrick M Bergin

Law firm

Patrick M Bergin VON BRIESEN & ROPER, S.C.

Docket

040957.00006

Address

411 E. WISCONSIN AVENUE, SUITE 1000, MILWAUKEE, WI 53202, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateJan 08, 2021

Serial Number90454786

Registration No.6920626

Registration DateDec 13, 2022

Status DateDec 13, 2022

Published for OppositionSep 27, 2022

Mark TypeStandard characters

Attorney Docket040957.00006

Status DescriptionLive and registered

Filing Signals

FILED

2021

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 009Electronics, software & scientific instruments

US codes: 021, 023, 026, 036, 038

First use anywhere: Jan 31, 2014

First use in commerce: Jan 31, 2014

Class 041Education & entertainment services

US codes: 100, 101, 107

First use anywhere: Jan 31, 2014

First use in commerce: Jan 31, 2014

Education; providing of training; entertainment; sporting and cultural activities.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

15 events

REGISTERED-PRINCIPAL REGISTER

Dec 13, 2022

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Dec 13, 2022

NOTICE OF REGISTRATION CONFIRMATION EMAILED

PUBLISHED FOR OPPOSITION

Sep 27, 2022

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Sep 27, 2022

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Sep 07, 2022

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Aug 23, 2022

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Oct 25, 2021

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Oct 25, 2021

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Oct 25, 2021

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Apr 24, 2021

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Apr 24, 2021

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Apr 24, 2021

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Apr 22, 2021

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Apr 08, 2021

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Jan 12, 2021

NEW APPLICATION ENTERED

MOLECULAR THERAPY ONCOLYTICS

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks in Class 009 — Electronics, software & scientific instruments

Other Marks by Patrick M Bergin

Resources

Company